Elisaf MS - Search Results

1

Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.

Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Liamis GL, Kakaidi B, Tselepis AD, Cariolou MA, Elisaf MS. Christidis DS, et al. Among authors: elisaf ms. Arch Med Res. 2007 May;38(4):403-10. doi: 10.1016/j.arcmed.2007.01.006. Arch Med Res. 2007. PMID: 17416287

2

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD. Tsimihodimos V, et al. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):306-11. doi: 10.1161/hq0202.102918. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834533 Clinical Trial.

3

HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.

Miltiadous G, Cariolou MA, Elisaf M. Miltiadous G, et al. Ann Clin Lab Sci. 2002 Winter;32(1):50-4. Ann Clin Lab Sci. 2002. PMID: 11848618

4

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Tsimihodimos V, et al. J Lipid Res. 2002 Feb;43(2):256-63. J Lipid Res. 2002. PMID: 11861667 Free article.

5

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

Liberopoulos E, Karabina SA, Tselepis A, Bairaktari E, Nicolaides C, Pavlidis N, Elisaf M. Liberopoulos E, et al. Oncology. 2002;62(2):115-20. doi: 10.1159/000048256. Oncology. 2002. PMID: 11914596

6

Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.

Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. Eur J Heart Fail. 2002 Mar;4(2):167-73. doi: 10.1016/s1388-9842(01)00234-3. Eur J Heart Fail. 2002. PMID: 11959045 Free article.

7

The hyponatremic patient: a systematic approach to laboratory diagnosis.

Milionis HJ, Liamis GL, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. CMAJ. 2002 Apr 16;166(8):1056-62. CMAJ. 2002. PMID: 12002984 Free PMC article. Review.

8

The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.

Achimastos A, Liberopoulos E, Nikas S, Bairaktari E, Miltiadous G, Tsimihodimos V, Elisaf M. Achimastos A, et al. Curr Med Res Opin. 2002;18(2):59-63. doi: 10.1185/030079902125000273. Curr Med Res Opin. 2002. PMID: 12017210

9

Multiple metabolic abnormalities in a patient with the syndrome of inappropriate antidiuresis.

Rizos E, Liamis G, Elisaf M. Rizos E, et al. Nephron. 2002 Jun;91(2):339-40. doi: 10.1159/000058416. Nephron. 2002. PMID: 12053077

10

Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine.

Bairaktari E, Seferiadis K, Liamis G, Psihogios N, Tsolas O, Elisaf M. Bairaktari E, et al. Clin Chem. 2002 Jul;48(7):1106-9. Clin Chem. 2002. PMID: 12089184 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

527 results

Search Page

Filters